A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management

Abstract

In Belgian patients, a simplified regimen using budesonide/formoterol maintenance and reliever therapy was at least as effective at improving clinical control compared with CBP with a significantly lower ICS dose and significantly lower drug costs.